By blocking the effects of these hormones at the receptor level, spironolactone helps manage these frustrating conditions
Rybelsus Rybelsus, the oral tablet form of semaglutide, expires two years from the date of manufacture
Even with insurance, many plans require prior authorization, step therapy through cheaper medications first, or simply do not cover weight loss indications at all
Monthly follow-ups monitor your progress, manage any side effects, and adjust dosing
The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial programme demonstrated that adults using semaglutide 2.4 mg weekly alongside lifestyle intervention lost an average of approximately 15% of their body weight over 68 weeks, compared to around 2.4% with placebo. NICE approved Wegovy for use in specialist weight management services in the UK in 2023 (TA875), recognising its clinical effectiveness. Ongoing research continues to explore its cardiovascular benefits, with the SELECT trial showing a significant reduction in major cardiovascular events in people with obesity
